Correlation Between Hookipa Pharma and Akero Therapeutics
Can any of the company-specific risk be diversified away by investing in both Hookipa Pharma and Akero Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hookipa Pharma and Akero Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hookipa Pharma and Akero Therapeutics, you can compare the effects of market volatilities on Hookipa Pharma and Akero Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hookipa Pharma with a short position of Akero Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hookipa Pharma and Akero Therapeutics.
Diversification Opportunities for Hookipa Pharma and Akero Therapeutics
-0.69 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Hookipa and Akero is -0.69. Overlapping area represents the amount of risk that can be diversified away by holding Hookipa Pharma and Akero Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akero Therapeutics and Hookipa Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hookipa Pharma are associated (or correlated) with Akero Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akero Therapeutics has no effect on the direction of Hookipa Pharma i.e., Hookipa Pharma and Akero Therapeutics go up and down completely randomly.
Pair Corralation between Hookipa Pharma and Akero Therapeutics
Given the investment horizon of 90 days Hookipa Pharma is expected to under-perform the Akero Therapeutics. In addition to that, Hookipa Pharma is 1.12 times more volatile than Akero Therapeutics. It trades about -0.52 of its total potential returns per unit of risk. Akero Therapeutics is currently generating about 0.12 per unit of volatility. If you would invest 2,867 in Akero Therapeutics on August 24, 2024 and sell it today you would earn a total of 253.00 from holding Akero Therapeutics or generate 8.82% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Hookipa Pharma vs. Akero Therapeutics
Performance |
| Timeline |
| Hookipa Pharma |
| Akero Therapeutics |
Hookipa Pharma and Akero Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Hookipa Pharma and Akero Therapeutics
The main advantage of trading using opposite Hookipa Pharma and Akero Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hookipa Pharma position performs unexpectedly, Akero Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akero Therapeutics will offset losses from the drop in Akero Therapeutics' long position.| Hookipa Pharma vs. Mereo BioPharma Group | Hookipa Pharma vs. Terns Pharmaceuticals | Hookipa Pharma vs. PDS Biotechnology Corp | Hookipa Pharma vs. Inozyme Pharma |
| Akero Therapeutics vs. Lyra Therapeutics | Akero Therapeutics vs. Hookipa Pharma | Akero Therapeutics vs. Cingulate Warrants | Akero Therapeutics vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |